In Phase A, participants will obtain distinctive doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra individuals are going to be enrolled on the determined monotherapy dosign program. In Segment B, individuals will obtain oral ruxolitinib and ABBV-744 are going to be offered as "insert-on" therapy. https://isabbv-744effectiveforhem79124.estate-blog.com/31298088/the-best-side-of-abbv-744-clinical-trial-phase-1-results